Have a personal or library account? Click to login
Inhibitory effect of terfenadine on Kir2.1 and Kir2.3 channels Cover

Inhibitory effect of terfenadine on Kir2.1 and Kir2.3 channels

Acta Pharmaceutica
Volume 71 (2021): Issue 2 (June 2021)
By: Mayra Delgado-Ramírez,  Fanny Junue Rodriguez-Leal,  Aldo Azmar Rodríguez-Menchaca,  Eloy Gerardo Moreno-Galindo,  José Antonio Sanchez-Chapula and  Tania Ferrer  
Open Access
|Nov 2020

Authors

Mayra Delgado-Ramírez

Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima

Fanny Junue Rodriguez-Leal

Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima

Aldo Azmar Rodríguez-Menchaca

Departamento de Fisiología y Biofísica, Facultad de Medicina, Universidad Autónoma de San Luis Potosí

Eloy Gerardo Moreno-Galindo

Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima

José Antonio Sanchez-Chapula

Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima

Tania Ferrer

tania@ucol.mx

Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima
DOI: https://doi.org/10.2478/acph-2021-0017 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 317 - 324
Accepted on: Jun 28, 2020
Published on: Nov 4, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
terfenadine,
inward rectifier potassium channels,
phosphatidylinositol 4,5-bisphosphate,
cationic amphiphilic drugs
Related subjects:
Pharmacy,
Pharmacy, other

© 2020 Mayra Delgado-Ramírez, Fanny Junue Rodriguez-Leal, Aldo Azmar Rodríguez-Menchaca, Eloy Gerardo Moreno-Galindo, José Antonio Sanchez-Chapula, Tania Ferrer, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 71 (2021): Issue 2 (June 2021)